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Methods: Participants 60 years and older with mild cognitive impairment (MCI) or subjective memory complaints (SMC)
with at least 1 cerebrovascular risk factor recruited from The Australian Imaging Biomarkers and Lifestyle Flagship Study
of Aging (AIBL) were randomized to a PA or control group (n = 106). The control group continued with their usual lifestyle.
The PA group received a 24-month home-based program with a target of 150 minutes/week of moderate PA and a behavioral
intervention. Retention (participants remaining) and PA adherence (PA group only, percent PA completed to the PA prescribed)
were determined at 6, 12, 18, and 24 months. Assessments at baseline, 6, 12, and 24 months included, PA; fitness; body
composition and fat distribution. Key outcome measures were PA adherence and PA.
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Results: The 24-month retention rate (97.2%) and the median PA adherence 91.67% (Q1–Q3, 81.96, 100.00) were excellent.
In the long-term the intervention group achieved significantly better improvements in PA levels, leg strength, fat mass and
fat distribution compared to the control.
38
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Conclusion: This study demonstrates that in this target group, long-term PA adherence is achievable and has physical health
benefits.
41
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INTRODUCTION31
Physical activity (PA) interventions resulting in32
increased PA and/or aerobic fitness have demon-33
strated an improvement in cognition in individuals34
with mild cognitive impairment (MCI) or subjec-35
tive memory complaints (SMC) who are at increased36
risk of Alzheimer’s disease (AD) [1, 2]. PA interven-37
tions have been shown to also provide improvements38
in fitness, function, mobility, and strength [3–5] in39
individuals with MCI or AD. Cerebrovascular risk40
factors (CVR) including physical inactivity, obesity,41
hypertension, heart disease, type II diabetes, smok-42
ing, and hypercholesterolemia, have been associated43
with increased risk for AD and may be additive [6,44
7]. Mid-life adiposity and central obesity have been45
associated with a greater risk of dementia in older46
age (≥65 years) [8, 9] with higher obesity being47
associated with greater dementia risk [10]. Physical48
inactivity and mid-life obesity have been identified as49
modifiable risk factors for AD [11]. Increasing PA has50
the potential to reduce fat mass and increase muscle51
mass and may be an effective lifestyle modification52
in preserving cognitive function in older age. Identi-53
fying effective PA interventions may have additional54
advantages of not only reducing the risk of AD from55
inactivity but also from obesity. The effect of PA on56
these outcomes depends on adherence to the PA pro-57
gram however there is a lack of evidence as to what58
strategies are effective in increasing adherence to PA59
interventions in populations at risk [12].60
Few PA intervention studies have been long-term,61
with most ranging from 9 weeks to 12 months [5]. A62
recent systematic review concluded that supervised63
multi-modal exercise for 60 min 2–3 days a week 64
can improve physical function (strength, mobility, 65
walking endurance/cardiovascular fitness) in indi- 66
viduals with various levels of cognitive impairment 67
[5]. However, it is not known if unsupervised or 68
home-based programs can achieve the same results 69
in physical function. We have previously reported 70
good short-term adherence and short and long-term 71
improvements in PA levels with a 6-month home- 72
based PA program in participants with MCI and 73
SMC [1, 13]. Lam et al. [5] reported that functional 74
improvements diminished from 9 weeks to 9 months 75
after the completion of the intervention supporting the 76
view that PA programs need to be continued to main- 77
tain improvements. It is unknown if PA programs can 78
be sustained in the long-term to maintain the improve- 79
ments in function and health initiated in short-term 80
interventions in this target group. 81
To our knowledge, no other group has investigated 82
in a group at increased risk of AD with CVR factors 83
if they can be motivated to increase their PA, and if 84
this confers fitness, body weight, and body composi- 85
tion benefits in the short and/or long-term. This study 86
addresses the problems of an increase in physical 87
inactivity with age, an increase in obesity, a decline 88
in muscle mass and the increased risk of AD, frailty, 89
and functional fitness. It highlights the challenges of 90
motivating older adults with cognitive concerns or 91
difficulties to maintain beneficial PA levels. 92
Thus, the aim of the current study was to investi- 93
gate whether individuals with cognitive problems and 94
additional CVR factors could increase their PA and 95
maintain adherence to a PA program over 24 months. 96
Furthermore, the aim was to evaluate the effects of 97
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the PA program on functional fitness, body weight98
and body composition of individuals at risk of AD.99
METHODS100
Study design101
The methods of this parallel single-blind random-102
ized controlled trial have been previously published103
in detail [14]. The CONSORT statement was used as104
the framework for development of the methodology105
for this trial. The main outcome of the study was the106
change in white matter hyperintensities on MRI in107
the brain after the 24-month intervention. To achieve108
a medium effect size of 0.5, 80% statistical power,109
and a two-sided alpha error level of 0.05, it was esti-110
mated that 65 participants would be needed for each111
group. With an estimated 15% loss to follow-up the112
aim was to recruit 78 participants per group.113
This paper reports the results for the secondary out-114
comes of retention, PA adherence, PA, fitness, body115
mass, and body composition measures. Protocols116
relevant to this paper are described briefly below.117
Participants gave informed written consent and the118
study was approved by the Melbourne Health Human119
Research Ethics Committee. The project complies120
with the Declaration of Helsinki 1975.121
Participants122
Recruitment and screening123
Men and women, aged 60 years and older, with124
MCI or subjective memory complaints (SMC) and125
at least 1 CVR factor (physical inactivity, obesity,126
hypertension, heart disease, type II diabetes, smok-127
ing, hypercholesterolemia), were recruited from the128
Melbourne cohort of the observational study The129
Australian Imaging Biomarkers and Lifestyle Flag-130
ship Study of Ageing (AIBL) [15] to participate in131
the AIBL Active trial. Potential participants were132
identified for inclusion and then invited to undertake133
a telephone-screening interview. The phone screen-134
ing included the 15-item Geriatric Depression Scale135
(GDS–15) [16] to establish the presence of clini-136
cally relevant symptoms of depression. Those with137
a score of 6 and higher were excluded. Participants’138
general practitioners were asked to consent to their139
patients’ involvement in the study. In addition to the140
above criteria participants were included in the study141
if they were community dwelling, and understood142
written and spoken English. All participants had a143
subjective memory complaint, e.g., all answered yes144
to the question “do you have any problems with your 145
memory?". A standardized procedure was used for 146
classification of MCI, which included use of a neu- 147
ropsychology measure (the Consortium to Establish 148
a Registry for Alzheimer’s disease (CERAD) battery) 149
and a global clinical measure (the Clinical Demen- 150
tia Rating (CDR) scale). The CERAD battery has 151
been shown to be one of the more sensitive tests for 152
detecting MCI [17] and was completed as part of the 153
test battery. The CDR was scored by NL an experi- 154
enced old age psychiatrist, and a total score of 0.5 155
was required for classification of MCI. 156
Participants were excluded if they: a diagnosis 157
of dementia or a Standardized Mini-Mental State 158
Examination score (SMMSE) <24 [18]; were unable 159
to have MRI scans; had a self-reported harmful 160
use of alcohol; had an unstable or life-threatening 161
medical condition; had a medical condition that 162
contra-indicated PA; had severe visual or hear- 163
ing impairment; or were participating in another 164
randomized controlled trial. 165
Assessments 166
Physical activity, physical fitness, body weight, 167
body composition, health, lifestyle, and cognitive 168
outcomes were assessed at baseline, 6, 12, and 24 169
months. PA adherence was measured at 6, 12, 18, 170
and 24 months. 171
Measurements 172
Retention 173
Retention was defined as the number of partici- 174
pants remaining in the study at each time-point, 6, 175
12, 18, and 24 months. 176
Adherence 177
Adherence to the prescribed PA in the PA group 178
only was assessed from self-reported PA diaries that 179
recorded type, frequency, duration, and intensity of 180
the PA. Participants were given diaries in a simplified 181
calendar format with the prescription of individual- 182
ized PA sessions itemized on the relevant day for 183
completion. The participants marked off the PA ses- 184
sion when completed and recorded the perceived 185
intensity on the Borg perceived rate of exertion scale 186
[19]. Any changes to the prescribed PA were also 187
noted and taken into account for the calculation of 188
adherence. The diaries were returned by prepaid 189
mail at the end of each month. Weekly programs 190
sheets were also given to participants to place in a 191
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prominent place to remind them of their sessions.192
Adherence was calculated as the number of minutes193
of moderate PA completed relative to the prescribed194
150 min/week expressed as a percentage. This was195
determined for 4 stages of the 24-month interven-196
tion period and the total 24-month period; Stage197
1:0–6 months; Stage 2:6–12 months; Stage 3:12–18198
months; Stage 4:18–24 months. Two measures of199
adherence were calculated; AIBL Active adherence200
(AIBLADH) calculated from the PA prescribed for201
the study and total adherence (TotADH) which was202
the calculated from the PA already being done at base-203
line plus the amount of PA prescribed for the study.204
The latter measure was included to minimize and205
monitor any replacement of study PA for habitual PA.206
Physical activity207
Pedometer: Participants wore a pedometer (Digi-208
Walker SW-200, Yamax Inc., Tokyo, Japan) for five209
weekdays and the weekend and were requested to210
keep to their usual activities during that week. They211
were given instructions on how (above the right hip212
on a belt worn around the waist) and when (all wak-213
ing hours except when showering or partaking in214
water-based activity) to wear the pedometer, and to215
also record step counts in a 7-day pedometer diary.216
When the pedometer was not worn the time off and217
all activities done during this time were recorded. The218
pedometer and diary were returned by mail.219
CHAMPS (physical activity questionnaire for older220
adults): The pedometer provides an objective mea-221
sure of ambulatory PA but it does not provide any222
information about the intensity of the PA. As we223
were also interested in the intensity and duration of224
different intensities of PA we used the CHAMPS225
questionnaire in addition to the pedometer. This self-226
reported PA questionnaire, designed for older adults,227
collects information on various types of PA, their228
intensity (low, moderate, high, and very high), fre-229
quency, and duration recalled for a typical week over230
the past 4 weeks [20].231
Physical performance battery232
6-minute Walk Test: This test assesses cardiovas-233
cular fitness with the participant walking as far as234
possible around a standardized course in 6 min and235
the distance measured in meters [21]. Heart rate is236
recorded every minute, peak heart rate determined237
(Polar FS3c Heart Rate Monitor, Polar Electro Oy,238
Kempele, Finland), and rate of perceived exertion239
(RPE) measured at the end of the test [19].240
Sit-to-Stand Test: A test of functional lower limb 241
or leg strength. The participant sits in a standard chair 242
and stands up and down 5 times as quickly as possible 243
while being timed [22]. 244
Step Test (balance): A dynamic balance test with 245
the participant steeping one foot on then off a 7.5 cm 246
high step as many times as possible in 15 s without 247
using hand support [23]. 248
Timed Up and Go Test (TUG): The participant is 249
timed in seconds (s) while standing up from a stan- 250
dard chair, walking three meters and then returning 251
to sit again in the chair [24]. The TUG assesses leg 252
strength and agility. 253
Grip strength: Measured in kilog ams (kg) on both 254
dominant and non-dominant hands with a Smedleys 255
hand dynamometer [25]. 256
Injury and musculoskeletal conditions 257
All participants were asked to self-report any 258
injuries or musculoskeletal conditions, including the 259
type, location of the injury, and if this was caused by 260
PA on the demographic and lifestyle questionnaire. 261
Body mass, body composition, and body fat 262
distribution 263
All measures were taken in light clothing and 264
without shoes. Height was measured using a fixed 265
stadiometer. Body mass, fat mass, %fat, fat free mass, 266
and body mass index (BMI) were measured with bio 267
impedance using the Tanita Body Composition Ana- 268
lyzer (Tanita TBF-300, Japan). Body fat distribution 269
was assessed via waist and hip girths. Waist girth 270
was measured at the minimum circumference at waist 271
level and hip girth was the maximum circumference at 272
the level of the greatest posterior protuberance of the 273
buttocks. Girths were measured in centimeters (cm) 274
3 times using a steel tape (Lufkin, W606PM Cooper 275
industries SC, USA) with the median measure used 276
as the score. 277
Demographic and lifestyle questionnaire 278
Participants completed a questionnaire providing 279
information about demographic characteristics, self- 280
reported medical history, current medications, dietary 281
habits (serves/day vegetables, fruit, protein), alco- 282
hol consumption, and any injuries or musculoskeletal 283
complaints associated with PA. They were asked to 284
maintain their usual lifestyle except for the change in 285
PA prescribed to the intervention group. 286
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Veriﬁcation of CVR factors287
For the CVR factors and related medications a288
physician-researcher (ML) adjudicated on the medi-289
cal records obtained from each participant’s doctor.290
Program and content evaluation291
At 6 months, participants completed question-292
naires designed specifically for this study about293
aspects of the program as a whole including, enjoy-294
ment (e.g., ‘’How enjoyable did you find the physical295
activity program?”); understanding (e.g., ‘’Did you296
find it easy to follow the program we set out for297
you?”); as well as on specific components of the298
program and the resources (e.g., ‘’How helpful did299
you find the following items that we provided?”, for300
example: worksheets; newsletters; phone calls; ‘’Did301
you enjoy reading the manual and completing the302
worksheets?”). They answered ‘’yes” or ‘’no” and/or303
rated the item on a scale 1–5 with 1 being the least304
and 5 the highest score.305
Randomization and blinding306
At the completion of baseline assessments307
participants were randomized to study groups.308
Randomization was undertaken in blocks of six par-309
ticipants (three in each of the treatment arms). The310
blocks were generated in STATA 10 (StataCorp,311
TX, USA). An investigator not directly involved in312
the recruitment or assessment of participants per-313
formed the allocation of participants to a PA program314
(intervention) or usual care (control), concealed in315
envelopes. This was a single blind study in which the316
research staff involved in the collection of the main317
outcome variables were not made aware of group318
allocation. In this type of study, it is not practical319
to blind participants to the intervention and due to320
logistical difficulties a sham PA program was not321
employed. Blinding, however, was supported by the322
allocation of cognitive and physical assessments to323
different locations and explicit instructions to partic-324
ipants and research staff not to discuss issues related325
to PA during the assessments.326
Physical activity intervention327
Intervention328
The intervention package comprised three compo-329
nents; the PA program, the behavioral intervention330
package, and phone monitoring. The 24-month inter-331
vention period was divided into 4 stages. Stage332
1:0–6 months; Stage 2:6–12 months; Stage 3:12–18 333
months; Stage 4:18–24 months. The PA prescription 334
and type of activity was reviewed at the end of each 335
stage. Intervention participants attended an individ- 336
ual PA workshop within 2 to 4 weeks of their baseline 337
visit. During this 60-min session, the program manual 338
was given to participants and they received instruc- 339
tions on their PA program, recording and the use of 340
the behavioral intervention material. 341
Physical activity program 342
The PA program was individualized for each par- 343
ticipant by the addition of minutes of moderate PA to 344
their baseline habitual PA with a final target of at least 345
150 min/week of moderate intensity PA [26]. Partic- 346
ipants not doing any moderate to vigorous intensity 347
PA (MVPA) at baseline (defined as ‘inactive’) were 348
prescribed the standard walking program (SWP); 349
150 min/week of moderate walking completed pre- 350
dominantly as 3, 50-min sessions/ week (with the 351
option of 5, 30-min sessions/week) [13]. Partici- 352
pants doing some PA but not reaching the target 353
were prescribed two additional sessions/week. Those 354
achieving the target at baseline had one session added 355
to their PA. Sessions and the rating of perceived exer- 356
tion (RPE) [19] were recorded in diaries returned by 357
mail each month. If walking was not appropriate other 358
moderate intensity activities (RPE 10–12) were pre- 359
scribed taking into account health problems or other 360
limitations, for example swimming or cycling. The 361
PA started slowly and progressed gradually taking 8 362
weeks to reach the target amount and intensity. 363
Behavioral intervention 364
Educational material and recommendations for 365
a healthy lifestyle (excluding PA information), 366
were given to both groups. Intervention participants 367
received a manual containing the PA program and 368
the behavioral intervention (BI). The BI was based 369
on the Stages of Change model modified for PA [27] 370
which we have used previously [13, 28] and further 371
modified to include the personal regulation of goal 372
directed behavior or performance [29, 30]. Modifica- 373
tions included a greater emphasis on identifying and 374
setting goals, self-monitoring, giving relevant feed- 375
back, review of progress, and identifying action steps 376
to enhance self-regulation skills. 377
These strategies were introduced during the work- 378
shop and supported over the 24-month intervention 379
with 17 newsletters containing additional motivat- 380
ing material mailed at regular intervals (4-weekly in 381
Stage 1, 6-weekly Stages 2–4) and reinforced with 382
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18 phone calls (week 2 then 4-weekly in Stage 1,383
6-weekly Stages 2–4). The 15-min standardized and384
structured calls were used to monitor and give feed-385
back on the participant’s progress and encourage their386
continuing adherence.387
Control group388
The control group continued with their usual PA389
for the 24-month study period. In addition to the390
educational material, the control group (usual care)391
participants received newsletters containing generic392
non-PA information and were contacted by phone at393
the same frequency as the intervention group with394
conversation limited to everyday topics with no dis-395
cussion about PA. This was to ensure that the control396
and intervention group had similar study contact. The397
control group were offered A PA workshop at the end398
of the study.399
Statistical analysis400
All analyses were conducted using Stata 15 (Stat-401
aCorp. 2017. Stata Statistical Software: Release 15.402
College Station, TX: StataCorp LLC) and alpha was403
set at 0.05. Data were summarized using counts404
and proportions, means and standard deviations (sd),405
means and 95% confidence intervals (CI), or median406
and quartiles (Q1-Q3) as appropriate. The distri-407
butions of continuous outcomes were investigated408
for indications of deviation from normality and if409
found were log transformed when this produced an410
improvement. Random effects linear regression with411
maximum likelihood estimation was employed to test412
for differences in continuous outcomes over time413
between intervention and control groups using the414
interaction of time and group. Time was treated as a415
factor (categorical) variable. All random effects lin-416
ear regressions were bootstrapped to ensure p values417
were robust to any remaining departures from nor-418
mality. In order to investigate potential differences in419
the frequency of exercise at different intensity levels420
(from the CHAMPS questionnaire) between groups421
over time, a negative binomial random effects regres-422
sion was applied using a three-way interaction of423
time, group and intensity (low versus moderate, high424
and very high combined). Differences in the num-425
ber of minutes (<150 versus ≥150 min) of physical426
activity between groups over time was investigated427
in a mixed effects logistic regression model with428
a three-way interaction of time, group, and inten-429
sity. Models were run with and without adjustment430
for age, sex, and baseline BMI. The selection of431
co-variates was based on evidence from the literature 432
and previous experience with PA intervention studies. 433
Body composition models were run with and without 434
adjustment for age and sex. As the adjusted mod- 435
els did not change the result the unadjusted models 436
are reported. In the intervention group, only adher- 437
ence to the intervention was analyzed using quantile 438
regression due to persistent skew in the distribu- 439
tion. Quantile regression generates estimates based 440
on quantiles, by default the median, rather than the 441
mean which will be biased when the distribution is 442
skewed. A per person cluster variance adjustment 443
was applied to account for the lack of independence 444
between observations over time within participant. 445
The effects of being inactive at baseline, cognitive 446
status (MCI/SMC), and sex on PA adherence were 447
also examined in these regressions. 448
Differences in the change in the number of serves 449
of fruit, vegetables and protein between groups 450
were analyzed using mixed effects ordinal logistic 451
regression after combining the first two or last two 452
categories where numbers were small. The assump- 453
tion of proportional odds was assessed using the Brant 454
test. 455
RESULTS 456
Baseline characteristics 457
Baseline characteristics in the two groups for the 458
106 participants who started the study are shown in 459
Tables 1 and 2. The groups were well balanced for 460
baseline characteristics, except that the control group 461
appear to have more retirees, participants on blood 462
pressure medication, and higher alcohol intake. Fifty- 463
seven (53.8%) of the participants were women; 67% 464
(n = 71) were overweight or obese and 28.3% were 465
diagnosed with MCI (n = 30). Mean age was 73.16 466
(5.84) years; were well educated 14.16 (3.59) years; 467
45.8% (n = 48) were married or co-habitating; 73.6% 468
(n = 78) were retired from paid employment; 56.5% 469
(n = 61) and 31.5% (n = 34) were classified as ‘low 470
active’ or ‘sedentary’, respectively, based on their 471
pedometer score [31]. 472
Retention 473
The participant flow over 24 months is shown in 474
Fig. 1. The overall retention rates were 99.1% (6 475
months), 98.1% (12 months), 98.1% (18 months), 476
and 97.2% (24 months). There was no signifi- 477
cant between-group difference in retention rate. The 478
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Table 1
Baseline demographic and physical activity characteristics of participants in the 2 study
groups in the AIBL Active study conducted in Melbourne, Australia 2011–2014
Control Intervention
Group Group
(n = 51) (n = 55)
Age (y) 70.10 (5.97) 72.29 (5.64)
Sex (n, % female) 28 (52.8%) 29 (52.7%)
Education (y) 14.24 (3.58) 14.09 (3.62)
MCI (N, % of group) 16 (31.4%) 14 (25.5%)
Married/co-habit (n, % of group) 21 (42%) 27 (49.1%)
Retired (n, % of group) 41 (80.4%) 37 (67.3%)
SMMSE 28.78 (1.56) 28.56 (1.63)
Body Mass Index (kg·m–2) 26.47 (4.31) 27.46 (4.03)
Overweight/Obese (n, % of group) 31 (60.8%) 40 (72.7%)
Smokers (n, % of group) 2 (3.9%) 2 (3.6%)
Blood pressure medication (n, % of group) 21 (41.2%) 14 (25.5%)
Cholesterol medication (n, % of group) 18 (35.3%) 26 (47.3%)
aVascular risk factors (n) 2.00 (0, 4) 1.00 (0, 6)
aAlcohol consumed (gms/week ethanol) 77 (14.90, 121.10) 12.60 (0, 75.70)
Low Active (n, % of group) 29 (54.7%) 32 (58.2%)
Falls history last 6 months (n (%)) 21(41.2%) 14 (25.5%)
Values are mean and (SD), amedian and (Q1–Q3) unless described otherwise. MCI, mild
cognitive impairment; SMMSE, Standardized Mini-Mental State Examination score. Vas-
cular risk factors include: physical inactivity, obesity, hypertension, heart disease, type II
diabetes, smoking, and hypercholesterolemia. ‘Low active’ was defined as <7500 steps/day
for the pedometer score [37].
Table 2
Adherence to the prescribed and total physical activity program over 24-months for the intervention group in the AIBL Active study conducted
in Melbourne, Australia 2011–2014
Adherence Stage 1 Stage 2 Stage 3 Stage 4 Total Change over
0–6 Months 6–12 Months 12–18Months 18–24 Months 0–24 Months time p value
(n = 48) (n = 46) (n = 40) (n = 40)
AIBLADH 91.67 93.17 93.33 92.48 91.67 0.90
(Median, Q1–Q3) (83.12, 100.00) (80.83, 100.00) (82.77, 100.00) (80.98, 100.00) (81.96, 100.00)
TotADH 81.46 81.10 86.25 82.41 81.83 0.30
(Median, Q1–Q3) (68.88, 92.56) (74.02, 92.13) (71.42, 94.25) (59.90, 90.08) (69.38, 92.29)
AIBLADH denotes (%Prescribed adherence), TotADH denotes, (%Total PA adherence). Values are median scores and (Q1-Q3). The p value
reflects the interaction p value that tests for a difference over time within the intervention group with adjustment for sex, MCI status, and
baseline ‘inactive’.
control participant who withdrew did so before479
the start of the intervention and the two interven-480
tion participants withdrew at 46 and 94 weeks into481
the 96-week intervention. Reasons why participants482
(n = 3) withdrew from the study are also shown in483
Fig. 1.484
Physical activity adherence485
Two participants declined the intervention after486
baseline and did not receive a PA program. Fifty-three487
(96.3%) attended the workshop session; however,488
a further 5 did not start the intervention but they489
returned for some follow-up assessments. Of the 7490
who did not start the PA intervention, 4 were already491
active at baseline and 3 were inactive. Forty-eight492
(87.2%) participants recording at least 1 session are 493
included in the adherence results. Fourteen partici- 494
pants (26.4%) not engaged in PA at baseline were 495
prescribed the standard walking program (SWP). For 496
the 24-month intervention period, the median scores 497
for the prescribed PA (AIBLADH) and the total 498
PA (TotADH) were 91.67% (Q1–Q3, 81.96, 100.00) 499
and 81.83% (69.38, 92.99), respectively. The median 500
adherence scores for the 4 intervention stages and 501
the overall 24-month period are shown on Table 2. 502
There was no evidence of a significant variation in 503
either of these adherence measures over time. Fur- 504
ther, sex, MCI status, or baseline inactivity did not 505
change these results. The mean RPE (PA intensity) 506
over the 24 months was 11.39 (11.22, 11.56) with no 507
evidence of a variation in the pattern of change over 508
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Fig. 1. AIBL Active study participant flow from recruitment to the end of the 24-month follow-up. Note: Some participants missed visits
for unknown reasons at an earlier follow-up but returned for the assessment at a later follow-up.
time (p = 0.36) which was within the target range of509
10–12. Walking was the most frequent PA type, with510
79.7% (n = 39) with an additional 4.1% (n = 2) for511
each of swimming/water walking, circuit gym and512
cycling and an additional 2% for aerobics, social513
dance, tennis, and croquet.514
Physical activity level 515
Pedometer scores 516
The PA measured by pedometer in steps/day for 517
the 24 months is shown in Table 3a and Fig. 2. 518
The difference in the pattern of change over time 519
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Table 3
(a) Daily pedometer steps over 24 months, (b) Minutes/week of all physical activity over 24-months (c) number of participants self-reporting
150minutes/week of moderate or higher intensity PA (CHAMPS questionnaire) for the control and intervention groups in the AIBL Active
study conducted in Melbourne, Australia 2011–2014
0 Months 6 Months 12 Months 24 Months Change
Control (n = 51) (n = 48) (n = 50) (n = 50) over time
Intervention (n = 55) (n = 52) (n = 50) (n = 52) p value
(a) Pedometer PA (steps/day)
Control 6708.91 6318.39 5642.61 5906.79 0.04
(5966.29,7544.12) (5363.53, 7443.19) (4774.15, 6692.70) (5111.04,6826.43)
Intervention 6244.20 7134.05 6729.03 6290.61
(5331.47,7313.20) (5954.52, 8547.22) (5708.24,7927.65) (5397.23,7331.86)
(b) Self-reported PA (CHAMPS) (min/week)
Control 750 705 810 900 0.12
(Median, Q1–Q3) (540, 1035) (532.5, 937.5) (555, 1020) (660, 1050)
Intervention 780 832.5 802.5 772.5
(Median, Q1–Q3) (495, 1065) (577.5, 1147.5) (585, 1050) (547.5, 1125)
(c) Self-reported > moderate PA
≥150 mins/week
Control (n, (%)) 32 (62.75) 29 (56.86) 39 (76.47 38 (74.51) 0.18
Intervention (n, (%)) 35 (63.64) 43 (78.18) 40 (72.73) 40 (72.73)
(a) Values are geometric mean (95% CI), (b) Values are median scores and (Q1–Q3), (c) Values are number (n) of participants and % of
group. The p value reflects the interaction p value that tests for a difference between groups over time. (b) When adjusted for sex, MCI status,
and baseline ’inactive’ the result was similar. (a) and (c) When adjusted for age, sex, and BMI the result was similar.
Fig. 2. Change in physical activity over the 24-months study measured as steps/day from the pedometer scores. Values are geometric mean
and 95% margins. Control Group ; Intervention Group . There was a significant difference in the pattern of change in physical
activity (steps/day) over time between the control and intervention group (p = 0.04). The p value reflects the interaction p value that tests for
a difference between groups over time.
between the two groups was significant (p = 0.04).520
There was a significant 15.4%, 1035.85 steps/day521
reduction for the control group from baseline to522
12 months (p = 0.008) with the decline persisting to523
24 months with a 13.4%, 899.70 steps/day reduc-524
tion from baseline to 24 months (p = 0.004). The525
intervention group maintained their steps/day over 526
time. 527
CHAMPS questionnaire 528
Table 3b shows the minutes of self-reported 529
‘all physical activity’ recorded from the CHAMPS 530
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Table 4
Cardiovascular fitness, mobility, leg strength, grip strength and balance results over the 24-month period for the control and intervention
groups in the AIBL Active study conducted in Melbourne, Australia 2011–2014
0 Months 6 Months 12 Months 24 Months Change
Control (n = 51) (n = 48) (n = 49) (n = 48) ver time
Intervention (n = 55) (n = 49) (n = 47) (n = 44) p value
Walk distance (m)
Control 499.56 (468.21, 524.92) 504.16 (476.92, 531.40) 509 (481.49, 538.05) 497.10 (466.48, 527.72) 0.61
Intervention 488.0 (465.09, 510.90) 507.32 (480.80, 533.84) 511.95 (484.61, 539.31) 514 54 (488.29, 540.80)
TUG (s)
Control 6.57 (5.92, 7.23) 6.60 (6.10, 7.11) 6.82 (6.22, 7.43) 6.88 (6.31, 7.45) 0.68
Intervention 6.39 (6.00, 6.78) 6.43 (5.95, 6.91) 6.32 (5.88, 6.76) 6.49 (5.97, 7.01)
Sit to Stand (s)
Control 11.03 (10.06, 12.00) 11.04 (10.10, 11.98) 11.24 (10.25, 12.23) 11.38 (10.64, 12.13) 0.02
Intervention 11.68 (10.80, 12.57) 11.24 (10.39, 12.10) 10.25 (9.58, 10.91) 10.68 (9.90, 11.47)
Grip Strength (kg)
(Dominant hand)
Control 30.52 (27.91, 33.14) 29.96 (26.95, 32.97) 30.48 (27.74, 33.21) 29.11 (26.33, 31.89) 0.83
Intervention 33.51 (31.13, 35.90) 32.52 (29.98, 35.07) 32.86 (30.27, 35.46) 31.00 (28.48, 33.53)
Grip Strength (kg)
(Non-dominant)
Control 28.48 (25.84, 31.11) 27.86 (25.15, 30.56) 27.67 (24.82, 30.52) 26.33 (23.66, 28.99) 0.94
Intervention 31.06 (28.85, 33.27) 29.96 (27.61, 32.30) 30.02 (27.56, 32.47) 28.39 (25.97, 30.81)
Step Test (steps)
Control 15.07 (14.07, 16.08) 14.81 (13.65, 15.96) 15.28 14.10, 16.45) 14.96 (13.88, 16.03) 0.88
Intervention 15.25 (14.91, 16.31) 15.41 (14.37, 16.45) 15.95 (14.72, 17.19) 15.66 (14.35, 16.97)
Values are mean and (95% CI). The p value reflects the interaction p value that tests for a difference between groups over time. When adjusted
for age, sex, and BMI the result was unchanged.
questionnaire at each assessment over the 24 months.531
There was no significant difference in the pattern of532
minutes over time between the 2 groups (p = 0.12) and533
after adjustment for age, sex, and BMI the result was534
unchanged. The number of participants self-reporting535
more than 150 min/week of moderate intensity or536
higher PA over the 24 months is shown in Table 3c.537
Similarly, there was no significant difference in the538
pattern of change over 24 months. The pattern of539
change over time between the 2 groups for frequency540
of activities and the energy expended in PA was not541
significant (results not shown).542
Physical performance543
The fitness test battery results are shown on Table 4.544
When age, sex, and BMI were included in the545
regression analyses the results were unaltered so the546
reported results are unadjusted values.547
Cardiovascular ﬁtness548
For walk distance (cardiovascular fitness) the dif-549
ference in the pattern of change over time between550
the groups was not significant. For the control group551
the pattern of change over time in walk distance was552
not significant. In the intervention group the pattern553
of change over time for walk distance increased from554
baseline by 17.80 (–1.69, 37.29) m (p = 0.074), 16.80555
(–3.78, 37.39) m (p = 0.110), and 18.22 (2.60, 33.84) 556
m (p = 0.022) at 6, 12, and 24 months, respectively. 557
This significant change from baseline to 24 months 558
in the intervention group represents an increase of 559
3.73% in cardiovascular fitness. 560
Leg strength 561
There was a significant difference in the pattern of 562
change over time between the control and interven- 563
tion group for the sit to stand test (s) the measure of leg 564
strength (p = 0.016) (Fig. 3). There was no evidence 565
for a change over time in sit to stand time in the control 566
group. There were significant changes over time for 567
sit to stand time in the intervention group. Compared 568
to the control group the reduction the test time for 569
the intervention group from baseline to 6, 12 and 24 570
months was 0.43 (95%CI: (1.11, 0.24) s (p = 0.209), 571
1.19 (2.01, 0.37) s (p = 0.004), and 0.83 (1.52, 0.14) s 572
(p = 0.017), respectively. This represents a 10.2% and 573
7.1% improvement in leg strength in the intervention 574
group at 12 and 24 months. 575
Balance 576
There was no significant difference in the pat- 577
tern of change over time for balance (step test) 578
between the control and intervention group. Fur- 579
ther, there was no evidence of any change over 580
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Fig. 3. Change in timed sit to stand test (leg strength) over the 24-months study. Values are predicted mean (seconds) and 95% margins. A
reduction in time indicates an increase in leg strength. Control Group ; Intervention Group . There was a significant difference
in the pattern of change over time for leg strength between the control and intervention group (p = 0.02). The p value reflects the interaction
p value that tests for a difference between groups over time. Compared to the control group the reduction the test time for the intervention
group from baseline to 6, 12, and 24 months was 0.43 (95%CI: (1.11, 0.24) s (p = 0.209), 1.19 (2.01, 0.37) s (p = 0.004), and 0.83 (1.52,
0.14) s (p = 0.017), respectively.
time in balance scores for the control or intervention581
group.582
Mobility583
There was no evidence of a significant difference584
in the pattern of change over time for the 2 groups585
in mobility (TUG). Nor were there any significant586
changes over time for the TUG score for the control587
or intervention group.588
Grip strength589
The difference in the pattern of change over time590
between the control and intervention group in grip591
strength for either the dominant or non-dominant592
hand was not significant (p = 0.83 and p = 0.94),593
respectively.594
Injury and musculoskeletal conditions595
Over the 24 months, 8.4% (n = 9) of partici-596
pants reported an injury or musculoskeletal condition597
related to PA. The incidence was similar for both598
groups 8% (n = 4) and 9% (n = 5) for the control and599
intervention group, respectively. The most reported600
injury was knee tendonitis or arthritis (n = 4) with 2601
out of 3 reports for the intervention group related to602
exacerbation of pre-existing conditions. Foot fasci-603
itis was reported by 2 participants, although this was 604
attributed to work and household PA as well as recre- 605
ational PA; hip muscle soreness (n = 2) and calf strain 606
(n = 1) accounted for the other reported conditions. 607
Body mass and body composition 608
Body mass, body composition, BMI, waist and hip 609
circumference results are shown on Table 5. Figure 4 610
shows the pattern of change in body mass, fat mass, 611
and fat-free mass over the 24-months. 612
Body mass and BMI 613
There was no significant difference in the pattern 614
of change over time in body mass between the con- 615
trol and the intervention group (p = 0.14). When the 616
analysis was adjusted for sex and age the results did 617
not change. 618
The results for BMI were similar with no signifi- 619
cant difference in pattern of change over time in BMI 620
(p = 0.11). 621
Fat mass and % body fat 622
There was a significant difference in the pat- 623
tern of change over time in fat mass between the 624
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Table 5
BMI, body mass, body composition, and waist and hip circumference results over the 24-month period for the
control and intervention groups in the AIBL Active study conducted in Melbourne, Australia 2011–2014
0 Months 6 Months 12 Months 24 Months Change
Control (n = 51) (n = 48) (n = 50) (n = 50) over time
Intervention (n = 55) (n = 52) (n = 51) (n = 52) p value
BMI (kg/m2)
Control 26.47 26.56 26.67 26.61 0.11
(25.25, 27.68) (25.22, 27.90) (25.39, 27.91) (25.22, 27.99)
Intervention 27.46 26.80 27.18 27.10
(26.37,28.55) (25.73, 27.87) (26.04, 28.31) (25.99, 28.20)
Body Mass (kg)
Control 71.71 71.00 71.27 71.25 0.14
(67.51, 74.84) (67.07, 74.94) (67.62, 74.91) (67.41, 75.09)
Intervention 76.15 73.98 75.42 75.16
(72.02,80.27) (70.15, 77.82) (71.10, 79.73) (71.00, 79.33)
Fat Mass (kg)
Control 21.92 22.40 22.78 22.16 0.03
(19.64,24.20) (20.07,24.74) (20.12, 25.43) (19.74, 24.57)
Intervention 24.25 22.73 23.73 23.48
(21.80, 26.69) (20.36, 25.10) (21.22, 26.24) (21.03, 25.93)
% Body Fat
Control 30.61 31.97 31.54 31.09 0.07
(28.33, 32.9) (29.51, 34.43) (29.15, 33.93) (28.82, 33.35)
Intervention 31.34 30.36 31.13 30.88
(29.07, 33.61) (28.02, 32.70) (28.84, 33.41) (28.58, 33.19)
Fat-free Mass (kg)
Control 48.27 47.63 47.52 47.93 0.85
(45.61, 51.08) (44.92, 50.50) (45.01, 50.17) (45.31, 50.70)
Intervention 50.87 49.99 50.29 50.34
(48.19, 53.70) (47.49, 52.63) (47.56, 53.17) (47.56, 53.27)
Waist circumference (cm)
Control 88.88 88.27 89.77 89.61 0.47
(85.39, 92.37) (84.71, 91.83) (86.24, 93.30) (85.81, 93.42)
Intervention 91.46 89.65 90.34 91.49
(87.77, 95.15) (86.15, 93.15) (86.47, 94.22) (87.85, 95.13)
Hip circumference (cm)
Control 102.28 102.66 102.93 102.10 0.02
(99.59, 104.96) (99.95, 105.37) (100.21, 105.64) (99.23, 104.95)
Intervention 104.98 102.96 103.01 102.21
(102.42, 107.55) (100.54, 105.38) (100.43, 105.59) (99.73, 104.68)
Values are mean and (95% CI) Value for fat-free mass is geometric mean and (95% CI). The p value reflects the interaction
p value that tests for a difference between groups over time. When adjusted for age, sex, and BMI the result was unchanged.
control and intervention (p = 0.03). From baseline to625
6 months there was a significant change in the inter-626
vention group of –1.12 (–1.80, –0.43) kg (p = 0.001)627
with no significant change over time in the control628
group which constituted a difference between the two629
groups of 1.33 (0.44, 2.23) kg.630
For %body fat there was no significant differ-631
ence in the change over time between the groups632
(p = 0.078).633
Fat-free mass634
There was no significant difference between635
groups in change over time in fat-free mass636
(p = 0.857). Further, there was no significant change637
over time in fat-free mass within either group for any638
stage.639
Waist circumference 640
For waist circumference, the pattern of change over 641
time between the two groups was not significant. 642
Hip circumference 643
For hip circumference there was a significant dif- 644
ference in the pattern of change over time between the 645
control and intervention group (p = 0.020) (Table 5 646
and Fig. 5). 647
In the intervention group, the change over time 648
from baseline to 6, 12, and 24 months in hip circum- 649
ference was 1.72 (0.24, 3.20) cm, (p = 0.022), 2.44 650
(0.75, 4.13) cm, (p = 0.005), and 2.22 (0.60, 3.83) cm 651
(p = 0.007) lower than the control group, respectively. 652
The result was unchanged when adjusted for age and 653
sex. 654
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Fig. 4. Change body mass, fat mass and fat-free mass over the 24-month study. Values are predicted mean (kg) and 95% margins. Control
Group ; Intervention Group . There was a significant difference in the pattern of change over time for fat mass (kg) between the
control and intervention group (p = 0.03). The p value reflects the interaction p value that tests for a difference between groups over time.
Dietary habits655
No significant difference in the change over time656
was detected for fruit, vegetable or protein intake657
(p = 0.33, p = 0.31, and p = 0.55, respectively).658
Program evaluation659
At 6 months 91% and 85% of control and interven-660
tion participants completed the program evaluation.661
In the intervention group enjoyment of the PA pro-662
gram was high (97.8%). The newsletters and phone663
calls were rated as “helpful – extremely helpful” by664
(94.3%) and (96.6%) of participants, respectively.665
The workbook was rated as “helpful – extremely666
helpful” by 97.7% of the intervention group with667
78% stating that they enjoyed completing the BI668
worksheets.669
DISCUSSION670
We have demonstrated that in this group of older671
adults at risk of AD and having at least 1 CVR factor,672
participants achieved excellent study retention and673
adherence to a moderate intensity PA program which 674
was maintained for 24 months. Further, the PA pro- 675
gram participants achieved an improved health profile 676
with sustained PA levels, improved leg strength, 677
lower fat mass and hip circumference in the long-term 678
and short-term improvements in body mass, when 679
compared to control participants. The results of the 680
program evaluation demonstrated that the program 681
was enjoyable, and acceptable. 682
To our knowledge, no other study has achieved 683
these levels of PA adherence over a 24-month period. 684
The median adherence score of 91.6% over the 24- 685
month period was in-line with the 87% that we 686
previously reported for a similar 6-month PA inter- 687
vention in older adults with and without memory 688
concerns [13], but higher than 71% for a 12-month 689
center-based walking program [32] and 79.2% for 690
a 12-month multicomponent exercise program [33]. 691
Even though 12.7% (n = 7) participants allocated to 692
the PA intervention failed to start the program this 693
was better than the non-start rate for other studies. 694
We previously reported a 22% non-start rate [20]. 695
van Uffelen et al. [32] reported 32% non-start and a 696
range of non-response rates of 21%–90% has been 697
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Fig. 5. Change hip circumference over the 24-months study. Values are predicted mean (cm) and 95% margins. Control Group ;
Intervention Group . There was a significant difference in the pattern of change over time for hip circumference (cm) between the
control and intervention group (p = 0.02). The p value reflects the interaction p value that tests for a difference between groups over time.
reported for home and group-based PA [34]. The rea-698
sons for not starting the PA program are unknown and699
the numbers are too few to speculate. It is noted, how-700
ever, that non-responders were from both the active701
and inactive categories at baseline. This highlights the702
problem of motivating older adults to firstly, initiate a703
PA program and underscores the need to find strate-704
gies to tackle this ongoing challenge in this target705
group.706
We did not observe any difference between the707
sexes in the uptake and maintenance of PA at any708
stage. This is in contrast to our previous study in709
which men achieved a 14% higher adherence to the710
prescribed PA during the 6-month intervention period711
[13]. The number of PA related injuries reported in712
this study was low and mostly due to previous con-713
ditions. This is consistent with our previous trial [13]714
demonstrating that older adults can engage a mod-715
erate intensity, predominantly walking PA program716
safely.717
The observation of a significant reduction in PA718
measured by the pedometer control group over the719
24 months was not unexpected as PA declines720
with age highlighting the need for PA to continue721
to be promoted during older age. The 15.4% and722
13.4% reduction translates into approximately 73 and723
63 min/week less moderate intensity PA (3 METS) at724
12 and 24 months for the control group [35]. The 725
magnitude of the reduction is substantial given it is 726
approximately the mean of 1day/week of PA at base- 727
line and nearly 50% of the 150 min/week of moderate 728
intensity PA recommended for good health [36]. Even 729
though the increase in PA by the intervention group 730
did not reach statistical significance, the difference 731
between the two groups in the pattern of change 732
over time was statistically significant, which sup- 733
ports a finding of successful maintenance of PA in 734
the intervention group. The inability to show a sig- 735
nificant difference in the intervention group is most 736
likely due to the relatively small group numbers and 737
lack of power. This maintenance of PA levels over 738
the 24-month period in the intervention group was 739
achieved with a home-based program employing a 740
BI, and although this was supported by mail-outs 741
and phone calls it was of low intensity. These results 742
underscore the importance of developing appropri- 743
ate strategies for this target group that achieve good 744
adherence [12] and persist in the long-term. Further, 745
this suggests that to achieve significant increases in 746
PA levels approaches may need to be more intensive. 747
PA measured via the CHAMPS questionnaire did 748
not show an increase in PA when compared to the 749
control group. That was not the case with the objective 750
measure using the pedometer. As this questionnaire 751
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relies on the recall of PA in a typical week over the752
past month in this target group of individuals with753
memory concerns it is possible that the result was a754
consequence of inaccurate recall. Thus highlighting755
the need for PA interventions in this target group to756
use objective measures of PA.757
While cardiovascular fitness did not differ in the758
pattern of change between the two groups over the759
period of the intervention, this is not surprising.760
Previous studies have similarly failed to observe a761
difference between control and intervention in fitness762
[37]. Further, this sample included some participants763
who were already doing some moderate intensity764
PA at baseline which limited the amount of PA that765
could be added to the participant’s PA program. Only766
the ‘inactive’ group at baseline (26.4%) were pre-767
scribed the amount recommended to improve health768
and fitness of 150 min/week of moderate intensity PA.769
Since the magnitude of change in fitness is related to770
baseline levels and the PA load, then the expected771
change would be small in magnitude. Thus limit-772
ing our ability to achieve higher levels of change773
in cardiovascular fitness. Further, the control group774
continued with their habitual PA again limiting our775
ability to show a large relative change between the776
two groups. However, it was encouraging to note that777
the relative increase from baseline to 24 months in the778
distance walked for the intervention group of 18.22 m779
was close to the range (19–22 m) considered to be a780
clinically relevant increase in fitness [38] and was781
similar in magnitude to that reported by Lamb et al.782
[39].783
The improvement in leg strength with the home-784
based PA program was consistent with the results785
of a meta-analysis of center-based supervised PA786
interventions in people with cognitive impairment787
[5]. This is an important result as the specificity788
of the training is important for improved outcomes789
[5]. Although our PA program was predominantly790
walking and not strength training based, we achieved791
improvements similar to those that were mostly mul-792
timodal or resistance training programs. This finding793
of a 7% improvement in leg strength over the 24794
months in the intervention group is relevant demon-795
strating that a walking program has the potential to796
not only reduce the decline in strength with age but to797
increase leg strength, thus potentially improving bal-798
ance and physical function [39]. This is very salient,799
as individuals with MCI are reported to have higher800
levels of motor dysfunction than other older adults801
[40, 41]. In the current study we did not observe a802
difference between the groups on the balance test803
even though leg strength improved which is a finding 804
that has been previously reported [42]. The lack of 805
finding of a difference between the control and inter- 806
vention group in grip strength was not unexpected 807
as the PA program utilized walking which uses lower 808
leg muscles whereas grip strength involves hand mus- 809
cles and improvements with training are seen to be 810
related to specificity of training [5]. Similarly, the lack 811
of improvement in mobility (TUG) with the PA pro- 812
gram was not surprising as even though both the TUG 813
and PA program involve walking the performance of 814
the TUG also requires leg strength and reaction time 815
(in getting up and down from a chair), fast walking 816
speed and agility in changing direction. The walk- 817
ing program engaged in by our participants did not 818
specifically target these skills thus it is not surpris- 819
ing that we did not demonstrate an improvement in 820
mobility. Improvements in physical function are spe- 821
cific to the type of training, and need to be of sufficient 822
frequency and/or duration to improve, balance, hand 823
strength and mobility [5]. These authors also reported 824
in their systematic review of exercise training and 825
physical function in MCI and AD participants that 826
studies including community-based participants only 827
reported no significant results. They suggested that 828
their higher baseline values in these functional out- 829
comes means they have less room for improvement. 830
In the current study, the inability to show a significant 831
difference between groups may also have been due to 832
the relatively small group size and lack of power. 833
The finding of a difference between groups in the 834
change fat mass over the 24-months with a reduc- 835
tion of fat mass in the intervention group and this 836
taken in conjunction with a preservation of fat-free 837
mass is important and relevant for this target group as 838
weight loss has been shown to often precede AD [43]. 839
This ‘obesity paradox’ raises the question if increas- 840
ing PA results in a reduction in body weight does this 841
reduction potentially increase the risk of AD in older 842
adults already at increased risk? Exercise is often an 843
adjunct to energy restriction in weight loss programs 844
as reducing energy intake alone results in both fat loss 845
and loss of fat-free mass [44]. The major component 846
of fat-free mass is muscle mass. Preserving muscle 847
mass is important as we age. The loss of skeletal mus- 848
cle and strength with age is reported to be around 2% 849
per year after the age of 60 years and this loss can 850
affect daily activities [45–47]. This gradual loss of 851
muscle mass and function known as ‘sarcopenia’ has 852
also been associated with cognitive impairment [48]. 853
Further, higher levels of sarcopenia and frailty in indi- 854
viduals with AD and CVR are associated with adverse 855
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outcomes such as falls, disability and mortality [49].856
A supervised moderate intensity, walking program in857
combination with diet-induced weight loss has been858
shown to attenuate the loss of muscle mass [50]. In859
the current study, we did not have robust dietary mon-860
itoring and, although we cannot be certain that the fat861
loss was due to the walking program and not a reduc-862
tion in energy intake, taken together with the lack of863
a reduction in fat-free mass it is likely that PA was the864
major contributor. Further, as we demonstrated a sig-865
nificant difference between the two groups in PA but866
not the 6-minute walk test this highlights the possi-867
bility that the changes in body composition were due868
to the amount of the PA over the duration of the trial869
rather than the intensity of the PA which is needed870
to improve fitness. That is, the energy expenditure871
achieved by more steps over a longer period resulted872
in energy output that was sufficient to reduce fat mass873
but may not have been of sufficient intensity to stimu-874
late an increase in fitness. Even though the magnitude875
of the reduction in fat mass of 1.12 kg is not large,876
this translates into an even larger amount of weight877
lost. Given that an increase in weight of 0.5 kg/year878
is associated with an increase in all-cause mortality879
[51], our findings are clinically meaningful.880
Further, taken together with the reduction in hip881
circumference and the increase in leg strength in the882
intervention group this suggests that the loss of fat883
could have been from buttocks region but with preser-884
vation of the gluteal muscle mass which play a major885
role in the sit to stand task. Although we were not886
able to determine if this was the case, preservation of887
lower limb fat-free mass determined by dual-energy888
x-ray absorptiometry, ‘leaner’ thigh muscle deter-889
mined by CT and muscle fiber size determined by890
muscle biopsy has been reported with a walking inter-891
vention in older adults [50]. This novel finding is892
important, as it demonstrates that this PA interven-893
tion of moderate intensity walking has the potential894
to slow down the loss of muscle mass and strength895
seen with sarcopenia in this target group.896
We were not able to demonstrate a significant897
difference in central obesity (waist circumference)898
a recognized CVR factor between the control and899
intervention group. This may have been due to900
measurement variation as the waist circumference901
measure taken at the level of the minimum width,902
is subject to more observer error than the hip cir-903
cumference that has a reference of an anatomical904
landmark.905
One of the strengths of our study is that we inves-906
tigated the effects of a home-based PA intervention907
over a long-term period with 4 assessment periods 908
which is rare in healthy older populations, and to our 909
knowledge a first in this target group. We have been 910
able to demonstrate that such programs can increase 911
PA and that this increase is maintained. The excel- 912
lent retention and adherence to the prescribed amount 913
of PA enabled us to demonstrate a beneficial effect 914
on PA, leg strength, and body composition that are 915
not always apparent in the short–term. These results 916
highlight the need to develop effective strategies that 917
lead to sustained PA levels if the inclusion of mod- 918
est amounts of PA is to be translated into community 919
programs and have a meaningful effect on health sta- 920
tus. The utilization of the pedometer as an objective 921
measure PA rather than relying on participant recall 922
in a group who has memory concerns adds to the 923
strength of the study. The pedometer is limited how- 924
ever in the ability to determine the intensity of the 925
PA. A further strength is the relatively large number 926
of participants in a 24-month trial that was adequate 927
for some outcomes but for some outcomes even with 928
these numbers, we had limited power to be able to 929
detect a significant difference between groups. We 930
simplified the recording of the PA for the intervention 931
group by providing individualized diaries to record 932
their activity and supported both groups through- 933
out the 24 months with newsletters and phone calls 934
to enhance retention and adherence. The inclusion 935
of participants who may have already been doing 936
some moderate intensity PA limited the amount of 937
PA that could be prescribed, thus reducing our ability 938
to demonstrate an effect as the amount of PA pre- 939
scribed depended upon the baseline PA and this varied 940
within the intervention group. For those with higher 941
baseline PA levels the effects on some measures may 942
have been limited due to a ceiling effect. However, 943
the inclusion of non-sedentary participants does not 944
limit the generalizability of the results of this trial as 945
the PA classifications of our participants were similar 946
to those of Australians in the same age range [52] 947
Even though participants were asked not to change 948
other lifestyle habits and we only collected basic self- 949
reported dietary information and not detailed diet 950
records, we cannot be sure that the body composition 951
changes were not at least in part due to some change 952
in diet and a possible reduction in energy intake. We 953
used practical field measures for some outcomes such 954
as fitness and body composition and while these have 955
the advantage of being implemented and translated 956
for use in a community setting they have limitations. 957
Limitations in terms of the robustness and variability 958
of the measures may have reduced the ability of this 959
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trial to detect small changes between groups. Another960
limitation of this study is that we have reported several961
secondary outcomes in this paper and as the analyses962
have not been adjusted for multiple comparisons it963
is possible that some results may be subject to type964
1 error (false positives). However, it is also possible965
that by not reporting the unadjusted results there is966
the risk of a type 2 error where we report that there967
is no significant difference when there is one.968
The results of this trial have several implications969
for implementation in a community and clinical set-970
ting. Firstly, the PA regime of moderate intensity,971
predominantly walking, is achievable by older adults972
without major health conditions and this was demon-973
strated in this group of older adults with MCI and974
at least 1 CVR factor. Secondly, being home-based975
means that PA can be undertaken with minimal or no976
cost, overcomes the potential barrier of transporta-977
tion, and can be done at the individual’s convenience.978
Further, the low incidence of PA program related979
injury or musculoskeletal conditions and no major980
adverse events means that it can be engaged in safely.981
It also supports the findings of Hamer et al. [53] in982
older adults that sustained PA has health benefits but983
that these benefits are apparent even if PA is not984
taken up until later in life. In a longitudinal aging985
study, two-thirds of MCI cases were reported to be986
physically frail or pre-frail largely due to low muscle987
mass, slow gait speed, balance and gait impairment988
[54]. The improvement in leg strength, fat mass,989
and preservation of lean body mass reported in this990
study, if repeated in future trials, highlights the poten-991
tial of this modest, easily accessible, and acceptable992
walking program to be used in programs targeting993
older adults, in particular those with MCI or SMC994
to achieve improved health status and the preven-995
tion of disability. Importantly, the uptake of PA needs996
to be maintained, underscoring the need for salient997
strategies to motivate this target group to sustain their998
PA.999
In conclusion, in this target group at risk of AD and1000
having a co-existing CVR factor long-term PA adher-1001
ence is achievable, acceptable, and has health benefits1002
in terms of fitness, body composition, and potentially1003
attenuating sarcopenia and risk of disability.1004
Our novel results of high retention rates and excel-1005
lent long-term adherence to a PA intervention are1006
important for the global efforts to reduce dementia1007
risk. To date there are no effective pharmacological1008
treatments available for the prevention of cognitive1009
decline AD or dementia. This makes the modifi-1010
cation of lifestyle that reduces risk factors such as1011
physical inactivity, cognitive inactivity, mid-life obe- 1012
sity, hypertension, heart disease, diabetes, smoking, 1013
and hypercholesterolemia a crucial strategy. This 1014
is underscored by the estimate that a third of AD 1015
cases worldwide may be attributed to modifiable risk 1016
factors. Recently it was reported that with a 10% 1017
reduction in each risk factor each decade, by 2050 the 1018
estimated reduction in the prevalence of AD would 1019
be 8.3% [11]. We have previously identified a need 1020
for targeted, effective, and viable PA intervention in 1021
order to achieve a reduction in the risk from inac- 1022
tivity [55]. The current study demonstrates that such 1023
PA interventions are not only achievable and effec- 1024
tive in increasing PA long-term but are acceptable 1025
to the target group. Further the observed increase 1026
in leg strength and favorable improvements in fat 1027
mass and body fat distribution highlight the additional 1028
health benefits of PA interventions and the potential 1029
to reduce other risk factors for dementia. The moder- 1030
ate intensity PA intervention undertaken in this study 1031
was low risk, easily accessible, and possible for most 1032
older adults at minimal or no cost making it easily 1033
adaptable and available on a global scale. Hence high- 1034
lighting the potential for PA interventions to have a 1035
potent impact as a global strategy for the prevention 1036
of dementia. Future research needs to concentrate on 1037
finding successful strategies for the implementation 1038
of PA programs into the community. 1039
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